Xinxiang Li

10PUBLICATIONS
46CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Cancer cell biologyPredictive and prognostic markersMicro-manipulation
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Oct 31, 2026
GALE is a tumor-intrinsic checkpoint of Vγ9Vδ2 T cell-mediated killing.

|Jul 23, 2026
Standardized surgical procedure of proximally extended resection and sphincter-preserving surgery (Tianhe Procedure) for rectal cancer after radiotherapy (2025 version).

|Apr 09, 2026
PVT1-104aa derived from the 8q24 gene desert promotes colorectal cancer tumorigenesis.

Maoguang Ma, Mingdian Wang, Yufei Yang

|Apr 04, 2026
Inhibition of circulating glycocholic acid-regulated signaling potentiates immune checkpoint therapy in colorectal cancer.

Senlin Zhao, Jing Zhang, Yushuai Mi

|Sep 30, 2025
Organ Preservation via Immunotherapy-Based Total Neoadjuvant Therapy in Early Low Rectal Cancer (TORCH-E): A Multicenter, Open-label, Single-Arm, Phase II Study.

Fan Xia, Yajie Chen, Di Zhou

|Feb 07, 2025
WNT11 Promotes immune evasion and resistance to Anti-PD-1 therapy in liver metastasis.

Weiliang Jiang, Bingjie Guan, Hongcheng Sun

Pageof 2

Frequent Collaborators

2 joint publications

Qingguo Li

2 joint publications

Dawei Li

2 joint publications

Senlin Zhao

1 joint publications

Dakui Luo